Truist Financial Reaffirms “Buy” Rating for Vericel (NASDAQ:VCEL)
Vericel (NASDAQ:VCEL – Get Free Report)‘s stock had its “buy” rating reiterated by stock analysts at Truist Financial in a research note issued on Monday,Benzinga reports. They presently have a $61.00 price objective on the biotechnology company’s stock, down from their previous price objective of $67.00. Truist Financial’s price target would suggest a potential upside […]
Vericel (NASDAQ:VCEL – Get Free Report)‘s stock had its “buy” rating reiterated by stock analysts at Truist Financial in a research note issued on Monday,Benzinga reports. They presently have a $61.00 price objective on the biotechnology company’s stock, down from their previous price objective of $67.00. Truist Financial’s price target would suggest a potential upside […]
